Girish Malhotra Girish Malhotra is a CPhI Worldwide Annual Industry Report member, and the President of EPCOT International, USA.
Calling for ANDA Action June 21, 2017 Faster review and approval processes could lower drug costs. Can we axe approval times for abbreviated new drug applications down to three months? 1 min read